A case study showed that the increase in IFN-γ (as a form of treatment for other pathologies) caused the appearance of vitiligo (Kocer et al., 2009), and treatment with anti-IFN-γ significantly decreased vitiligo progression (Skurkovich and Skurkovich, 2006). The gene discussed is IFNG; the disease is vitiligo.